Skip to main content

Howard Colman, MD, PhD

Languages spoken: English

Clinical Locations

  • Howard Colman, MD, PhD, has multiple clinical interests including the treatment of primary and metastatic brain tumors, and the diagnosis and management of neurologic complications of cancer. His clinical research is focused on the development and testing of new therapies for brain tumors. His laboratory interests include the identification of molecular markers of prognosis and treatment response in brain tumors and the role of tumors stem cells in the development and treatment resistance of brain tumors. He is a Jon M. Huntsman Presidential Professor in the Department of Neurosurgery, a member of the multidisciplinary Brain Tumor Research Team, and is Leader of the Center for Neurologic Cancers at Huntsman Cancer Institute (HCI) at the University of Utah. He is also an HCI investigator and a member of the Experimental Therapeutics program.

    Board Certification and Academic Information

    Academic Departments Neurosurgery - Primary
    Internal Medicine - Adjunct
    Neurology - Adjunct
    Academic Divisions
    Oncology

    Patient Rating

    4.7/5

    The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

    Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Learn more about our survey

    Patient Comments

    Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    November 06, 2022

    Good

    November 06, 2022

    Lack of communication

    October 10, 2022

    They are very good

  • Howard Colman, MD, PhD, has multiple clinical interests including the treatment of primary and metastatic brain tumors, and the diagnosis and management of neurologic complications of cancer. His clinical research is focused on the development and testing of new therapies for brain tumors. His laboratory interests include the identification of molecular markers of prognosis and treatment response in brain tumors and the role of tumors stem cells in the development and treatment resistance of brain tumors. He is a Jon M. Huntsman Presidential Professor in the Department of Neurosurgery, a member of the multidisciplinary Brain Tumor Research Team, and is Leader of the Center for Neurologic Cancers at Huntsman Cancer Institute (HCI) at the University of Utah. He is also an HCI investigator and a member of the Experimental Therapeutics program.

    Board Certification and Academic Information

    Academic Departments Neurosurgery -Primary
    Internal Medicine -Adjunct
    Neurology -Adjunct
    Academic Divisions
    Oncology

    Research interests

    Education history

    Fellowship Neuro-Oncology - University of Texas M.D. Anderson Cancer Center Fellow
    Neurology - Washington University School of Medicine Chief Resident
    Residency Neurology - Barnes-Jewish Hospital, Washington University School of Medicine Resident
    Medicine - Barnes-Jewish Hospital, Washington University School of Medicine Intern
    Doctoral Training Neuroscience - Washington University School of Medicine Ph.D.
    Medicine - Washington University School of Medicine M.D.
    Undergraduate Neural Sciences - Brown University Sc.B.